Clinical Trials Browser

Unknown × lenvatinib × Thoracic × Clear all

NCT05296603 2024-01-10

Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT04989322 2021-12-08

Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung